Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP294959.RAm8C2Bp8f4rnuWuZK05nvHw7sQf50JU2uMCAz13LphCk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP294959.RAm8C2Bp8f4rnuWuZK05nvHw7sQf50JU2uMCAz13LphCk130_assertion type Assertion NP294959.RAm8C2Bp8f4rnuWuZK05nvHw7sQf50JU2uMCAz13LphCk130_head.
- NP294959.RAm8C2Bp8f4rnuWuZK05nvHw7sQf50JU2uMCAz13LphCk130_assertion description "[Hematological and cytogenetic response of interferon alpha 2b alone and combined interferon alpha plus cytarabine as a first-line treatment in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP294959.RAm8C2Bp8f4rnuWuZK05nvHw7sQf50JU2uMCAz13LphCk130_provenance.
- NP294959.RAm8C2Bp8f4rnuWuZK05nvHw7sQf50JU2uMCAz13LphCk130_assertion evidence source_evidence_literature NP294959.RAm8C2Bp8f4rnuWuZK05nvHw7sQf50JU2uMCAz13LphCk130_provenance.
- NP294959.RAm8C2Bp8f4rnuWuZK05nvHw7sQf50JU2uMCAz13LphCk130_assertion SIO_000772 10985480 NP294959.RAm8C2Bp8f4rnuWuZK05nvHw7sQf50JU2uMCAz13LphCk130_provenance.
- NP294959.RAm8C2Bp8f4rnuWuZK05nvHw7sQf50JU2uMCAz13LphCk130_assertion wasDerivedFrom befree-2016 NP294959.RAm8C2Bp8f4rnuWuZK05nvHw7sQf50JU2uMCAz13LphCk130_provenance.
- NP294959.RAm8C2Bp8f4rnuWuZK05nvHw7sQf50JU2uMCAz13LphCk130_assertion wasGeneratedBy ECO_0000203 NP294959.RAm8C2Bp8f4rnuWuZK05nvHw7sQf50JU2uMCAz13LphCk130_provenance.